X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15) 15
index medicus (15) 15
male (11) 11
oncology (11) 11
prostate cancer (10) 10
aged (9) 9
cancer (7) 7
middle aged (7) 7
urology (6) 6
antineoplastic agents - therapeutic use (5) 5
carcinoma, renal cell - drug therapy (5) 5
care and treatment (5) 5
chemotherapy (5) 5
kidney neoplasms - drug therapy (5) 5
research (5) 5
trial (5) 5
abiraterone acetate (4) 4
adult (4) 4
aged, 80 and over (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
disease-free survival (4) 4
docetaxel (4) 4
double-blind (4) 4
drug therapy (4) 4
hematology, oncology and palliative medicine (4) 4
metastasis (4) 4
neoplasm metastasis (4) 4
pharmacology & pharmacy (4) 4
prostatic neoplasms, castration-resistant - drug therapy (4) 4
prostatic neoplasms, castration-resistant - pathology (4) 4
urology & nephrology (4) 4
analysis (3) 3
androgen antagonists - therapeutic use (3) 3
antitumor-activity (3) 3
enzalutamide (3) 3
female (3) 3
original (3) 3
patient outcomes (3) 3
prednisone - administration & dosage (3) 3
prognosis (3) 3
prostatic neoplasms - drug therapy (3) 3
survival analysis (3) 3
abiraterone acetate - administration & dosage (2) 2
antineoplastic agents, hormonal - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
carcinoma (2) 2
carcinoma, renal cell (2) 2
carcinoma, renal cell - pathology (2) 2
combination (2) 2
corticosteroids (2) 2
disease progression (2) 2
double-blind method (2) 2
endothelial growth-factor (2) 2
expression (2) 2
indoles - administration & dosage (2) 2
interferon-alpha (2) 2
kidney neoplasms - pathology (2) 2
kinases (2) 2
medicine & public health (2) 2
men (2) 2
metastatic castration-resistant prostate cancer (2) 2
mitoxantrone plus prednisone (2) 2
neoplasm grading (2) 2
niacinamide - analogs & derivatives (2) 2
oncology, experimental (2) 2
pharmacology/toxicology (2) 2
phase-iii trial (2) 2
placebo-controlled phase-3 (2) 2
prednisone (2) 2
prostatectomy (2) 2
prostatic neoplasms, castration-resistant - mortality (2) 2
protein kinase inhibitors - therapeutic use (2) 2
pyrroles - administration & dosage (2) 2
quality-of-life (2) 2
radiology, nuclear medicine & medical imaging (2) 2
receptor (2) 2
renal cell carcinoma (2) 2
safety (2) 2
sorafenib (2) 2
survival (2) 2
survival rate (2) 2
therapy (2) 2
transitional-cell-carcinoma (2) 2
treatment patterns (2) 2
tyrosine kinase inhibitor (2) 2
urinary bladder neoplasms - therapy (2) 2
urologic and male genital diseases (2) 2
1st-line treatment (1) 1
2005 international-society (1) 1
2nd-line everolimus (1) 1
[ sdv.imm ] life sciences [q-bio]/immunology (1) 1
abarelix (1) 1
ablation techniques (1) 1
absorption (1) 1
acetates (1) 1
advanced solid tumors (1) 1
adverse events (1) 1
age factors (1) 1
androgen antagonists - adverse effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 152 - 160
Journal Article
Journal Article
Annals of oncology : official journal of the European Society for Medical Oncology, ISSN 0923-7534, 2018, Volume 29, Issue 11, p. 2269
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 10/2017, Volume 99, Issue 2, pp. E266 - E266
Journal Article
by Li, Y and Yang, X and Su, L.J and Flaig, T.W
Journal of Urology, ISSN 0022-5347, 08/2011, Volume 186, Issue 2, pp. 456 - 457
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 71, Issue 4, pp. 656 - 664
Journal Article
Prostate Cancer and Prostatic Diseases, ISSN 1365-7852, 2014, Volume 17, Issue 1, pp. 34 - 39
Journal Article
Investigational New Drugs, ISSN 0167-6997, 2/2013, Volume 31, Issue 1, pp. 115 - 125
Journal Article
Journal Article
European Urology Supplements, ISSN 1569-9056, 2014, Volume 13, Issue 1, pp. e863 - e863
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 2013, Volume 368, pp. 138 - 148
BACKGROUND: Abiraterone acetate, an androgen biosynthesis inhibitor, improves overall survival in patients with metastatic castration-resistant prostate cancer... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 2012, Volume 367, pp. 1187 - 1197
BACKGROUND: Enzalutamide (formerly called MDV3100) targets multiple steps in the androgen-receptor-signaling pathway, the major driver of prostate-cancer... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.